Cello is an insight and strategic marketing group, listed on London’s AIM.
Cello is comprised of two distinct businesses: Cello Health and Cello Signal. Cello Health delivers cutting-edge professional marketing services to the global pharmaceutical and health sectors. Cello Signal delivers technically-led insight and marketing support services to global consumer and business-to-business clients.
Cello’s overall mission is to cut through the increasing clutter of market data and discover the real value of market information, allowing our clients across both of our businesses to make faster and better market decisions.
Cello delivers its services from office networks in the UK, USA, Singapore and Hong Kong, through a group of over 800 professionals.

Type
Public
HQ
London, GB
Founded
2004
Size (employees)
1,000 (est)+7%
Cello Group was founded in 2004 and is headquartered in London, GB
Report incorrect company information

Key People/Management at Cello Group

Mark Scott

Mark Scott

CEO
Jacqueline Briggs

Jacqueline Briggs

Vice President, Human Resources
Stephen Highley

Stephen Highley

Group Chief Operating Officer
Mark Bentley

Mark Bentley

Group Finance Director

Cello Group Office Locations

Cello Group has an office in London
London, GB (HQ)
11 Charterhouse Bldgs
Show all (1)
Report incorrect company information

Cello Group Financials and Metrics

Cello Group Financials

Cello Group's revenue was reported to be £169.29 m in FY, 2017
GBP

Revenue (FY, 2017)

169.3 m

Gross profit (FY, 2017)

102.5 m

Gross profit margin (FY, 2017), %

60.5%

Net income (FY, 2017)

4.2 m

EBITDA (FY, 2017)

8.8 m

EBIT (FY, 2017)

6.2 m

Market capitalization (31-Oct-2017)

131.7 m

Closing share price (31-Oct-2017)

1.3

Cash (31-Dec-2017)

13 m
Cello Group's current market capitalization is £131.7 m.
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

108.3 m137.6 m123.7 m125 m127.7 m135.1 m159.7 m169.9 m156.7 m165.3 m169.3 m

Revenue growth, %

(52%)103%5%

Cost of goods sold

51.5 m72.3 m64 m64.7 m65.9 m70 m85 m88.9 m70.3 m72.6 m66.8 m

Gross profit

56.8 m65.4 m59.7 m60.3 m61.8 m65.1 m74.7 m81 m86.5 m92.7 m102.5 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

7 m5.1 m3.1 m797 k4.2 m4.1 m6 m5.6 m5.2 m7.5 m13 m

Accounts Receivable

21.3 m19.8 m19 m20 m21.6 m23.8 m28.5 m29.9 m40.3 m43.3 m51 m

Current Assets

35.7 m31.7 m28.8 m27.2 m33.3 m34.1 m42.3 m45.6 m48.9 m54.3 m67.5 m

PP&E

3.3 m3.1 m2.5 m2.1 m2.2 m2.3 m2.2 m2.3 m2 m2.7 m2.8 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

3.1 m3.2 m(6 m)3.6 m(334 k)156 k3.6 m2.3 m3.3 m(2.5 m)4.2 m

Cash From Operating Activities

5.9 m7.8 m4.6 m7.1 m5.8 m6.1 m9.3 m2.4 m7 m4.9 m2.7 m

Dividends Paid

382 k556 k733 k814 k709 k1.4 m1.6 m2.6 m2.2 m2.6 m3.6 m

Cash From Financing Activities

2.5 m(5.1 m)(4.3 m)(7.7 m)1.4 m(1.1 m)(5.3 m)13 k(6.1 m)(836 k)10.2 m
GBPY, 2017

Revenue/Employee

174.5 k

Financial Leverage

1.8 x
Show all financial metrics
Report incorrect company information